Evolve Biologics is advancing what’s possible in our industry. | Evolve Biologics
Evolve is a new kind of biologics company. We’re built around a next-generation technology for bringing critical therapeutics to the people who need them. We believe our patented next-generation technology, PlasmaCap EBA®, is the first major advancement in the field since the 1940s. We believe it will help us deliver critical plasma-derived therapeutics at higher levels of purity, efficiency, and quality than conventional methods can. We believe our patented technique, PlasmaCap EBA®, is the first major innovation in this area in the past 80 years. We believe this technique will allow us to advance the quality of plasma-derived therapeutics. Because our technology is proprietary and protected, and we have direct control of our manufacturing, we expect our supply to be more consistent and predictable than today’s options. We think it’s about time someone advanced the way biologics are delivered.
This company is:
Verified
Evolve Biologics, Therapure Biopharma’s Biologics Division, Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering | Evolve Biologics
28 Mar, 2018 - Mississauga, ON, Canada – March 28, 2018 – Evolve Biologics, the biologics division of Therapure Biopharma Inc., today announced that in February 2018 the company confidentially submitted a draft registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to the proposed initial public offering of its common shares. The initial public offering is expected to commence after the SEC completes its review process, subject to market and other conditions.
Verified
Technology | Evolve Biologics
Learn more about PlasmaCap EBA, Evolve’s proprietary and patented technology for protein extraction and how it plays a key role in our developing portfolio.
Verified
Evolve Biologics Provides Business Update on Progress Toward Commercialization of Innovative Plasmacap EBA® Technology | Evolve Biologics
10 Mar, 2021 - Mississauga, ON, Canada (March 10, 2021) – Evolve Biologics Inc. (“Evolve”), an innovative plasma-derived therapeutics company, today provided an update on its continued progress toward the development and commercialization of its PlasmaCap EBA technology and its strong position as an innovative developer and manufacturer of these critical products.
View all products
Keywords
Industries
Where is Evolve Biologics located?
The company Evolve Biologics is located in Mississauga, Ontario, Canada. It's worth noting that the company may has more corporate locations
How many employees does Evolve Biologics approximately have?
As of the latest available information Evolve Biologics has around 11-50 employees worldwide.
When was Evolve Biologics founded?
Evolve Biologics was founded in 2017
In which industries does Evolve Biologics mainly work?
The company Evolve Biologics has it's main focus in the industries of Biotechnology, Science and Engineering, Health Care
Evolve Medtech Partners
United States
1-10 Employees
2018
G2O Water Technologies Ltd
United Kingdom
11-50 Employees
2015
EVQLV
United States
1-10 Employees
Evolve Biologix
Canada
1-10 Employees
2016
Generon (Shanghai) Corporation
China
51-100 Employees
2004
Jupiter Therapeutics
United States
1-10 Employees
2017
Evolve Limited
Malta
11-50 Employees
2006
EV Biologics
United States
Topics which have been searched by others and may be interesting for you:
